SM Optics

SM Optics is an Italian technology company specializing in optical transport solutions and 5G network infrastructure, operating as a subsidiary of the SIAE MICROELETTRONICA Group. Although primarily a telecommunications firm, SM Optics is a key contributor to the life sciences sector through its expertise in biophotonics and optical sensing. The company participates in advanced European healthcare R&D initiatives, such as the PHAIDRA and PHAST projects, which focus on integrating optical imaging with medical robotics and developing high-precision diagnostic tools for oncology. Founded in 2014 through the acquisition of Alcatel-Lucent’s Italian optical R&D unit, SM Optics provides the critical hardware and software platforms required for high-speed data transmission and sophisticated sensing in modern clinical and laboratory environments.